Guido Marcucci
0000-0002-3983-5908
2 papers found
Refreshing results…
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
Missing publications? Search for publications with a matching author name.